---
$id: https://graph.org.ai/products/commodity/51142511
$type: Product
source: UNSPSC
code: "51142511"
title: "Entacapone"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Entacapone

**UNSPSC Code**: 51142511
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C14H15N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4975G9NM6T, chemically known as 2-propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-n,n-diethyl- but generally known as entacapone, which bears US NIH Compound Identifier 5281081. European Medicines Agency schedules Entacapone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06552MIG. The term ENTACAPONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules entacapone in its Anatomical Therapeutic Chemical (ATC) Classification. ENTACAPONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule entacapone under HS 29269095 and SITC 51484. As of Q4 2014, ENTACAPONE remains the US FDA Preferred Term for this commodity. Entacapone bears US NLM identifiers UMLS ID C0876730 and NCI Concept Code C61746. SMILES: O=C(N(CC)CC)/C(=C/C1CC([N](=O)O)C(O)C(O)C1)C#N.

